Mutational analysis of the estrogen receptor-α gene in familial ovarian cancer

Journal of Obstetrics and Gynaecology Research

Volumn 31, Issue 5, 2005, Pages 375-383

  Wu, Hong Jun ^a   Sekine, Masayuki ^a   Kashima, Katsunori ^a   Hirai, Yasuo ^b   Hatae, Masayuki ^c   Kobayashi, Iwao ^d   Obata, Koshiro ^e   Enomoto, Takayuki ^f   Umesaki, Naohiko ^g   Ushijima, Kimio ^h   Tanaka, Kenichi ^a   Araki, Tsutomu ⁱ   Kanazawa, Koji ^j   Kamata, Hiroyuki ^k   Kidera, Yoshiro ^l   Kudo, Takafumi ^m   Kuzuya, Kazuo ⁿ   Jimbo, Tsuneo ^o   Tsunematsu, Ryuichiro ^p   Toyoda, Nagayasu ^q   Nagata, Ichiro ^r   Hasegawa, Kazuo ^s   Mizunuma, Hideki ^t   Yajima, Masazumi ^u   Wada, Yuichi ^v   more..

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b CANCER INSTITUTE HOSPITAL   (Japan)

^c K   (Japan)

^d NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^e KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ NIPPON MEDICAL SCHOOL   (Japan)

^j UNIVERSITY OF THE RYUKYUS   (Japan)

^k TOCHIGI CANCER CENTER   (Japan)

^l Sasebo Kyosai Hospital   (Japan)

^m OKAYAMA UNIVERSITY   (Japan)

ⁿ AICHI CANCER CENTER HOSPITAL   (Japan)

^o TOKYO ROSAI HOSPITAL   (Japan)

^p National Cancer Center

^q MIE UNIVERSITY   (Japan)

^r NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^s HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^t GUNMA UNIVERSITY   (Japan)

^u TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^v SENDAI CITY MEDICAL CENTER   (Japan)

more..

Author keywords

BRCA1; Estrogen receptor ; Familial ovarian cancer; Polymorphism

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; DNA; ESTROGEN RECEPTOR ALPHA;

ADULT; AGED; ARTICLE; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GERM LINE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; JAPAN; MISSENSE MUTATION; MUTATIONAL ANALYSIS; ONCOGENE; OVARY CANCER; PEDIGREE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; DNA, NEOPLASM; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; OVARIAN NEOPLASMS; PEDIGREE; POLYMORPHISM, GENETIC;

EID: 27744511879     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2005.00305.x     Document Type: Article

References (34)

1. Schildkraut JM, Thompson WD. Familial ovarian cancer: A population-based case-control study. Am J Epidemiol 1988; 128: 456-466.
2. Hartge P, Whittemore AS, Itnyre J et al. Rates and risks of ovarian cancer in subgroups of white women in the United States. Obstet Gynecol 1994; 84: 760-764.
3. Hall JM, Lee MK, Newman B et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990; 250: 1684-1689.
4. Miki Y, Swensen J, Shattuck-Eidens D et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66-71.
5. Inoue R, Fukutomi T, Ushijima T et al. Germ-line mutation of BRCA1 in Japanese breast cancer families. Cancer Res 1995; 55: 3521-3524.
6. Sekine M, Nagata H, Tsuji S et al. Mutational analysis of BRCA1 and BRCA2 and clinicopathologic analysis of ovarian cancer in 82 ovarian cancer families: Two common founder mutations of BRCA1 in Japanese population. Clin Cancer Res 2001; 7: 3144-3150.
7. Lantta M. Estradiol and progesterone receptors in normal ovary and ovarian tumors. Acta Obstet Gynecol Scand 1984; 63: 497-503.
8. Vierikko P, Kauppila A, Vihko R. Cytosol and nuclear estrogen and progestin receptors and 17 beta-hydroxysteroid dehydrogenase activity in non-diseased tissue and in benign and malignant tumors of the human ovary. Int J Cancer 1983; 32: 413-422.
9. Godwin AK, Perez RP, Johnson SW et al. Growth regulation of ovarian cancer. Hematol Oncol Clin North Am 1992; 6: 829-841.
10. Clinton GM, Hua W. Estrogen action in human ovarian cancer. Crit Rev Oncol Hematol 1997; 25: 1-9.
11. Ponglikitmongkol M, Green S, Chambon P. Genomic organization of the human oestrogen receptor gene. EMBO J 1988; 7: 3385-3388.
12. Green S, Walter P, Kumar V et al. Human oestrogen receptor cDNA: Sequence, expression and homology to v-reb-A. Nature 1986; 320: 134-139.
13. Menasce LP, White GRM, Harrison CJ et al. Localization of the estrogen receptor locus (ER) to chromosome 6q25.1 by FISH and a simple post-FISH banding technique. Genomics 1993; 17: 263-265.
14. Green GL, Gilna P, Waterfield M et al. Sequence and expression of human estrogen receptor complementary DNA. Science 1986; 231: 1150-1154.
15. Andersen TI, Wooster R, Laake K et al. Screening for ESR mutation in breast and ovarian cancer cases. Hum Mutat 1997; 9: 531-536.
16. Lee JH, Kavanagh JJ, Wildrick DM et al. Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas. Cancer Res 1990; 50: 2724-2728.
17. Cooke IE, Shelling AN, Le Meuth VG et al. Allele loss on chromosome arm 6q and fine mapping of the region at 6q27 in epithelial ovarian cancer. Genes Chromosomes Cancer 1996; 15: 223-233.
18. Shridhar V, Staub J, Huntley B et al. A novel region of deletion on chromosome 6q23.3 spanning less than 500 Kb in high grade invasive epithelial ovarian cancer. Oncogene 1999; 18: 3913-3918.
19. Sandhu AK, Hubbard K, Kaur GP et al. A gene on 6q, 14-21 restores senescence to immortal ovarian tumor cells. Oncogene 1996; 12: 247-252.
20. Fujii H, Zhou W, Gabrielson E. Detection of frequent allelic loss of 6q23-q25.2 in microdissected human breast cancer tissues. Genes Chromosomes Cancer 1996; 16: 35-39.
21. Chappell SA, Walsh T, Walker RA et al. Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas. Br J Cancer 1997; 75: 1324-1329.
22. Dotzlaw H, Alkhalaf M, Murphy LC. Characterization of estrogen receptor variant mRNAs from human breast cancers. Mol Endocrinol 1992; 6: 773-785.
23. McGuire WL, Chamness GC, Fuqua SA. Estrogen receptor variants in clinical breast cancer. Mol Endocrinol 1991; 5: 1571-1577.
24. Wang M, Dotzlaw H, Fuqua SA. A point mutation in the human estrogen receptor gene is associated with the expression of an abnormal estrogen receptor mRNA containing a 69 novel nucleotide insertion. Breast Cancer Res Treat 1997; 44: 145-151.
25. Lemieux P, Fuqua S. The role of the estrogen receptor in tumor progression. J Steroid Biochem Mol Biol 1996; 56: 87-91.
26. Sambrook J, Fritsch EF, Maniatis T. Isolation of high-molecular-weight DNA from mammalian cells. In: Fritsch J, Maniatis T (eds). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989; 914-923.
27. Schubert EL, Lee MK, Newman B et al. Single nucleotide polymorphisms (SNPs) in the estrogen receptor gene and breast cancer susceptibility. J Steroid Biochem Mol Biol 1999; 71: 21-27.
28. Zuppan P, Hall JM, Lee MK et al. Possible linkage of the estrogen receptor gene to breast cancer in a family with late-onset disease. Am J Hum Genet 1991; 48: 1065-1068.
29. Iwase H, Yamashita H, Kobayashi S et al. Possibility of the linkage to the estrogen receptor gene in 4 Japanese breast cancer families. Jpn J Breast Cancer 1996; 11: 117-121.
30. Lehrer S, Levine E, Savoretti P et al. Oestrogen and progesterone receptor dissociation and family history of breast cancer. Lancet 1992; 339: 1108-1109.
31. Colitti CV, Rodabaugh KJ, Welch WR et al. A novel 4 cm minimal deletion unit on chromosome 6q25.1-q25.2 associated with high grade invasive epithelial ovarian carcinomas. Oncogene 1998; 16: 555-559.
32. Bell DW, Jhanwar SC, Testa JR. Multiple regions of allelic loss from chromosome arm 6q in malignant mesothelioma. Cancer Res 1997; 57: 4057-4062.
33. Queimado L, Reis A, Fonseca I et al. A refined localization of two deleted regions in chromosome 6q associated with salivary gland carcinomas. Oncogene 1998; 16: 83-88.
34. Gaidano G, Hauptschein RS, Parsa NZ et al. Deletions involving two distinct regions of 6q in B cell non-Hodgkin lymphoma. Blood 1992; 80: 1781-1787.